Quick Answer
CATALYST PHARMACEUTICALS, INC. reported Common Stock Shares Outstanding of 122.51 million shares for the year ending 2025.
- CATALYST PHARMACEUTICALS, INC. showed an increase of +1.4% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from CATALYST PHARMACEUTICALS, INC.'s annual report (Form 10-K), filed with the SEC on February 25, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), CATALYST PHARMACEUTICALS, INC.'s Common Stock Shares Outstanding has grown by 531.7%.
- Historical annual values: Fiscal year 2025: 122.51 million shares | Fiscal year 2024: 120.88 million shares | Fiscal year 2023: 107.12 million shares | Fiscal year 2022: 105.26 million shares | Fiscal year 2021: 102.99 million shares | Fiscal year 2020: 103.78 million shares | Fiscal year 2019: 103.40 million shares | Fiscal year 2018: 102.74 million shares | Fiscal year 2017: 102.55 million shares | Fiscal year 2016: 82.97 million shares | Fiscal year 2015: 82.85 million shares | Fiscal year 2014: 69.12 million shares | Fiscal year 2013: 54.13 million shares | Fiscal year 2012: 41.42 million shares | Fiscal year 2011: 24.70 million shares | Fiscal year 2010: 19.39 million shares.
- Data sourced from SEC EDGAR public filings as of June 22, 2026.
Last verified: